AstraZeneca PLC on Friday announced that its medication osimertinib, alongside chemotherapy, has been approved by the ...
Aptamer Group PLC on Wednesday said it reached an agreement with AstraZeneca PLC. The York, England-based biotechnol ...
AstraZeneca PLC 01 July 2024 1 July 2024 15:00 BST Transparency Directive Voting rights and capital The following notification is made...
AstraZeneca PLC on Monday said two cancer treatments had been recommended for approval in the European Union, while t ...
AstraZeneca PLC 01 July 2024 1 July 2024 Lynparza and Imfinzi combination recommended for approval in the EU by CHMP for patients with...
AstraZeneca PLC on Wednesday celebrated the approval of Tagrisso plus chemotherapy for a cancer form in China, a day ...
AstraZeneca PLC on Tuesday announced a mixed bag of results for two of its leading cancer drugs Imfinzi and Tagrisso. ...
AstraZeneca PLC 25 June 2024 25 June 2024 Update on ADJUVANT BR.31 Phase III trial of Imfinzi in non-small cell lung cancer High-level...
AstraZeneca PLC 25 June 2024 25 June 2024 Imfinzi demonstrated statistically significant and clinically meaningful improvement in...
AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.